Cencora, Inc. (COR) key performance indicators and operating metrics (34 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| U.S. Healthcare Solutions revenue | 74.86B | FY2026-Q3 |
| International Healthcare Solutions revenue | 7.68B | FY2026-Q3 |
| U.S. Healthcare Solutions segment operating income growth | 966.18M percent | FY2026-Q3 |
| Adjusted diluted earnings per share | 4.48 USD_per_share | FY2026-Q3 |
| Adjusted operating income | 1.2B | FY2026-Q3 |
| International Healthcare Solutions operating income | 165.95M | FY2026-Q3 |
| U.S. Healthcare Solutions operating income | 966.1M | FY2026-Q3 |
| Adjusted net income attributable to Cencora | 869M | FY2026-Q3 |
| Adjusted diluted earnings per share growth | 12.00 percent | FY2026-Q3 |
| Healthcare Solutions operating income margin | 2.16 percent | FY2026-Q3 |
| Adjusted effective tax rate | 19.90 percent | FY2026-Q3 |
| Healthcare Solutions gross profit margin | 14.58 percent | FY2026-Q3 |
| Adjusted gross profit | 3.5B | FY2026-Q3 |
| Revenue growth | 5.10 percent | FY2026-Q3 |
Back to COR overview · COR earnings · COR holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.